The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Abstract
The 'expanded' HD CAG repeat that causes Huntington's disease (HD) encodes a polyglutamine tract in huntingtin, which first targets the death of medium-sized spiny striatal neurons. Mitochondrial energetics, related to N-methyl-d-aspartate (NMDA) Ca2+-signaling, has long been implicated in this neuronal specificity, implying an integral role for huntingtin in mitochondrial energy metabolism. As a genetic test of this hypothesis, we have looked for a relationship between the length of the HD CAG repeat, expressed in endogenous huntingtin, and mitochondrial ATP production. In STHdhQ111 knock-in striatal cells, a juvenile onset HD CAG repeat was associated with low mitochondrial ATP and decreased mitochondrial ADP-uptake. This metabolic inhibition was associated with enhanced Ca2+-influx through NMDA receptors, which when blocked resulted in increased cellular [ATP/ADP]. We then evaluated [ATP/ADP] in 40 human lymphoblastoid cell lines, bearing non-HD CAG lengths (9-34 units) or HD-causing alleles (35-70 units). This analysis revealed an inverse association with the longer of the two allelic HD CAG repeats in both the non-HD and HD ranges. Thus, the polyglutamine tract in huntingtin appears to regulate mitochondrial ADP-phosphorylation in a Ca2+-dependent process that fulfills the genetic criteria for the HD trigger of pathogenesis, and it thereby determines a fundamental biological parameter--cellular energy status, which may contribute to the exquisite vulnerability of striatal neurons in HD. Moreover, the evidence that this polymorphism can determine energy status in the non-HD range suggests that it should be tested as a potential physiological modifier in both health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationShah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citationGauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Self-citationEarly mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Flier, J. S., Underhill, L. H., Martin, J. B., & Gusella, J. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152006 · Cited by 550
Self-citationTranscriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515 · cited 2×
“Mitochondria were isolated according to a procedure described previously (39) and suspended in buffer A (5 mM HEPES, 3 mM MgCl2, 1 mM EGTA, 250 mM sucrose, pH 7.”
BackgroundMethodSelf-citationWidespread expression of Huntington's disease gene (IT15) protein product
Sharp, A. H., Loev, S. J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90345-3 · Cited by 513
Humbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., Greenberg, M. E., & Saudou, F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00188-0 · Cited by 509
Halestrap, A., & Brenner, C. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457278 · Cited by 503
Adenine Nucleotide Translocation of Mitochondria: 1. Specificity and Control
Pfaff, E., & Klingenberg, M. (1968) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1968.tb00420.x · Cited by 424
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
Gusella, J. F., & MacDonald, M. E. (2000) · Nature Reviews Neuroscience · doi:10.1038/35039051 · Cited by 404
Self-citationTranscriptional dysregulation in Huntington’s disease
Cha, J.-H. J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01609-x · Cited by 397
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
State-Dependent Calcium Signaling in Dendritic Spines of Striatal Medium Spiny Neurons
Carter, A. G., & Sabatini, B. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.013 · Cited by 344
Beal, M. F., Brouillet, E., Jenkins, B., Henshaw, R., Rosen, B., & Hyman, B. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03633.x · Cited by 300
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Gines, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg046 · Cited by 276
Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.08.001 · Cited by 268
Milakovic, T., & Johnson, G. V. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504749200 · Cited by 261
Deranged neuronal calcium signaling and Huntington disease
Bezprozvanny, I., & Hayden, M. R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.035 · Cited by 255
Lodi, R., Schapira, A. H. V., Manners, D., Styles, P., Wood, N. W., Taylor, D. J., & Warner, T. T. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<72::aid-ana11>3.0.co;2-i · Cited by 254
Bioenergetics and glutamate excitotoxicity
Greene, J. G., & Greenamyre, J. T. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00006-8 · Cited by 245
Pathogenesis of polyglutamine disorders: aggregation revisited
Michalik, A., & Van Broeckhoven, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg295 · Cited by 232
Isolation and Subfractionation of Mitochondria from Animal Cells and Tissue Culture Lines
Pallotti, F., & Lenaz, G. (2007) · Methods in Cell Biology · doi:10.1016/s0091-679x(06)80001-4 · Cited by 229
Adenine Nucleotide Translocation of Mitochondria. Kinetics of the Adenine Nucleotide Exchange
Pfaff, E., Heldt, H. W., & Klingenberg, M. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00715.x · Cited by 226
Bcl-2 and Bax modulate adenine nucleotide translocase activity.
Belzacq, A.-S., Vieira, H. L. A., Verrier, F., Vandecasteele, G., Cohen, I., Prévost, M., Larquet, É., Pariselli, F., Petit, P. X., Kahn, A., et al. (2003) · PubMed · Cited by 194
Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
Saft, C., Zange, J., Andrich, J., Müller, K., Lindenberg, K., Landwehrmeyer, B., Vorgerd, M., Kraus, P. H., Przuntek, H., & Schöls, L. (2005) · Movement Disorders · doi:10.1002/mds.20373 · Cited by 183
Takano, H., & Gusella, J. F. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-15 · Cited by 177
Self-citationComplex I Defect in muscle from patients with Huntington's disease
Arenas, J., Campos, Y., Ribacoba, R., Martín, M. A., Rubio, J. C., Ablanedo, P., & Cabello, A. (1998) · Annals of Neurology · doi:10.1002/ana.410430321 · Cited by 173
Zeron, M. M., Fernandes, H. B., Krebs, C., Shehadeh, J., Wellington, C. L., Leavitt, B. R., Baimbridge, K. G., Hayden, M. R., & Raymond, L. A. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.11.014 · Cited by 170
Prospero, N. D., Chen, E.-Y., Charles, V., Plomann, M., Kordower, J., & Tagle, D. (2004) · Journal of Neurocytology · doi:10.1007/s11068-004-0514-8 · Cited by 152
Polyglutamines Placed into Context
Spada, A. R. L., & Taylor, J. P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00328-3 · Cited by 142
Barbiero, G., Duranti, F., Bonelli, G., Amenta, J. S., & Baccino, F. M. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1104 · Cited by 137
Ginés, S., Ivanova, E. V., Seong, I., Saura, C. A., & MacDonald, M. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309348200 · Cited by 136
Self-citationCroup: Pathogenesis and management
Goldhagen, J. L. (1983) · Journal of Emergency Medicine · doi:10.1016/0736-4679(83)90003-3 · Cited by 135
Ravikumar, B., Stewart, A., Kita, H., Kato, K., Duden, R., & Rubinsztein, D. C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg109 · Cited by 118
MacDonald, M. E., Ginés, S., Gusella, J. F., & Wheeler, V. C. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:7 · Cited by 117
Self-citationPanov, A. V., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00585-4 · Cited by 116
Bioenergetics in Huntington's Disease
Grünewald, T. G. P., & Beal, M. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07827.x · Cited by 110
Ruan, Q., Lesort, M., MacDonald, M. E., & Johnson, G. V. W. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh082 · Cited by 104
Self-citationPanov, A. V., Lund, S. A., & Greenamyre, J. T. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3454-9 · Cited by 101
Chapter 1 Isolation and subfractionation of mitochondria from animal cells and tissue culture lines
Pallotti, F., & Lenaz, G. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)65002-7 · Cited by 96
Trushina, E. V., Heldebrant, M. P., Pérez-Terzic, C. M., Bortolon, R., Kovtun, I. V., Badger, J. D., Terzic, A., Estévez, Á. G., Windebank, A. J., Dyer, R. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034961100 · Cited by 90
Autophagosome-like vacuole formation in Huntingtonʼs disease lymphoblasts
Nagata, E., Sawa, A., Ross, C. A., & Snyder, S. H. (2004) · Neuroreport · doi:10.1097/01.wnr.0000127073.66692.8f · Cited by 89
Nitrogen Cavitation for Cell Disruption to Obtain Mitochondria from Cultured Cells
Gottlieb, R. A., & Adachi, S. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)22022-3 · Cited by 82
Differential Expression of Normal and Mutant Huntington's Disease Gene Alleles
Persichetti, F., Carlée, L., Faber, P. W., McNeil, S. M., Ambrose, C. M., Srinidhi, J., Anderson, M., Barnes, G. T., Gusella, J. F., & MacDonald, M. E. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0018 · Cited by 82
Self-citationExcitotoxic Injury to Mitochondria Isolated from Cultured Neurons
Kushnareva, Y. E., Wiley, S. E., Ward, M. W., Andreyev, A. Y., & Murphy, A. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503090200 · Cited by 75
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates
Brouillet, E., & Hantraye, P. (1995) · Current Opinion in Neurology · doi:10.1097/00019052-199512000-00014 · Cited by 65
Sawa, A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100223 · Cited by 53
Yohrling, G. J., Farrell, L. A., Hollenberg, A. N., & Cha, J.-H. J. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00032-0 · Cited by 48
Secondary abnormalities of mitochondrial DNA associated with neurodegeneration
Tabrizi, S. J., & Schapira, A. H. V. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660099 · Cited by 37
Schapira, A. H. V., & Lodi, R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-804-8:293 · Cited by 26
Schuh, R. A., Kristián, T., & Fiskum, G. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02873.x · Cited by 26
Cited by
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Self-citationTrinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,368
Huntington disease: natural history, biomarkers and prospects for therapeutics
Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., Paulsen, J. S., et al. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.24 · Cited by 1,016
Ageing and neuronal vulnerability
Mattson, M. P., & Magnus, T. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1886 · Cited by 957
Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562
Metadata
- Authors
- Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., Gusella, J. F., Laramie, J. M., Myers, R. H., Lesort, M., & MacDonald, M. E.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-22
- Volume
- 14
- Issue
- 19
- Pages
- 2871-2880
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2157590258
- Cited by
- 294
- References
- 62
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.